Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Cetuximab can cause unusual hair growth and hair loss.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

PLD is an effective and safer alternative for treating breast cancer.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

A 72-year-old man with sudden taste issues and hair growth was diagnosed with a severe stomach cancer and died within 5 months.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.